Tech Transfer Roundup: Arrakis Gets Penn IP Toward Small Molecule RNA Therapies

Canaan Partners-backed biotech will investigate the therapeutic potential of three-way junctions in folded RNA. UC Berkeley and Duke sign separate license agreements related to CRISPR gene-editing technology.